Аннотация
Background. Parenteral viral hepatitis B, C and D are one of the main problems of healthcare worldwide. Objective – to analyze the effect of viral hepatitis in the Republic of Kazakhstan at the present stage. Material and methods. The study used indicators of descriptive statistics of the scientific and practical center "Sanitary and Epidemiological Expertise and Monitoring" of the Committee for the Protection of Consumer Rights of the Ministry of National Economy (MNE) of the Republic of Kazakhstan (RK) and of the Committee for Statistics of the MNE of RK. Results. The introduction of a vaccination against hepatitis B into Vaccination schedule has led to a significant decrease in the incidence of viral hepatitis B among people under 18 years of age in the Republic of Kazakhstan. However, there is an increase in the incidence of delta hepatitis, for example, from 2012 to 2016, the incidence of chronic viral hepatitis B with delta agent in citizens over 18 years old increased by 50% and amounted to 0.57 cases per 100 thousand people. Conclusions. Taking into account the increase in access to highly active antiviral agents in the Republic of Kazakhstan, the paradigm of projected elimination of hepatitis C is presented. The study of hepatic steatosis is becoming relevant, due to the increasing rate of metabolic disorders worldwide, including the Republic of Kazakhstan.